# Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

> **NCT05066958** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 20 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- High Risk Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia, in Relapse
- High Risk Acute Lymphoblastic Leukemia
- Acute Biphenotypic Leukemia in Relapse
- Non-hodgkin Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** boost anti-viral immunity after T-cell depleted HSCT

## Key facts

- **NCT ID:** NCT05066958
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-16
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066958, "Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05066958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*